Annual report
4552.TEDINET S100TQM6
Period2023-04-01 → 2024-03-31
Filed2024-06-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥42.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥34.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥51.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥30.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥24.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥7.5bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥5.0bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥7.3bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥5.4bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥20.5bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.5bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.3bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥7.2bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥5.4bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥5.5bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥14.5bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.9bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.7bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥5.5bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥3.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥102.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥94.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥97.1bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥73.8bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥47.8bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥45.8bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥42.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥56.5bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥52.4bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥51.1bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥38.6bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥32.6bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥18.8bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥13.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥18.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥26.3bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥10.9bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥9.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥5.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥9.3bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥10.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.9bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥15.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.3bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.2bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥8.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥44.13 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.35 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥117.26 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.81 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.72 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥43.92 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.22 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.8 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥55.53 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥21.59 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥443.62 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥412.11 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥406.57 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥306.31 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥257.92 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 54.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.8% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.3% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.6% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 10.3% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 32.9% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.8% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.6% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 934 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 879 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 816 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 732 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 667 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥42.9bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥34.3bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥51.1bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥30.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥24.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥7.5bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥5.1bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥8.0bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥5.3bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥20.4bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.6bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.3bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥8.0bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥5.3bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥6.4bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥3.7bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥14.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥102.1bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥94.6bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥97.0bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥73.7bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥47.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥46.0bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥42.5bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥56.1bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥52.0bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥50.9bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥38.5bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥32.3bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥16.8bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥11.6bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥51 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.67 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.77 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥57.33 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.23 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥50.76 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥29.54 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.31 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥57.05 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.1 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥20 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥22 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25.5 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥32 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥443.32 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥410.86 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥407.02 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥307.64 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥257.01 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 54.2% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.2% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.9% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.6% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.9% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 32.7% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 20.3% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.9% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 129,686,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 129,686,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 129,686,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 129,686,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 32,421,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 900 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 854 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 797 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 719 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 654 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Businessreportable segment | employees | at 2024-03-31 | 934 pure |
| Pharmaceutical Businessreportable segment | employees | at 2024-03-31 | 900 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,444
| Item | Context | Value | Unit |
|---|---|---|---|
| Current liabilities | Prior1YearInstant | 35762000000 | JPY |
| Current liabilities | CurrentYearInstant | 30135000000 | JPY |
| Long term loans payable | Prior1YearInstant | 5500000000 | JPY |
| Long term loans payable | CurrentYearInstant | 14350000000 | JPY |
| Provision for employee stock ownership plan ncl | Prior1YearInstant | 95000000 | JPY |
| Provision for employee stock ownership plan ncl | CurrentYearInstant | 81000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 924000000 | JPY |
| Net defined benefit liability | CurrentYearInstant | 903000000 | JPY |
| Other ncl | Prior1YearInstant | 241000000 | JPY |
| Other ncl | CurrentYearInstant | 280000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 6761000000 | JPY |
| Noncurrent liabilities | CurrentYearInstant | 15615000000 | JPY |
| Liabilities | Prior1YearInstant | 42523000000 | JPY |
| Liabilities | CurrentYearInstant | 45750000000 | JPY |
| Capital stock | Prior1YearInstant | 9061000000 | JPY |
| Capital stock | CurrentYearInstant | 9061000000 | JPY |
| Capital surplus | Prior1YearInstant | 10384000000 | JPY |
| Capital surplus | CurrentYearInstant | 10384000000 | JPY |
| Retained earnings | Prior1YearInstant | 34273000000 | JPY |
| Retained earnings | CurrentYearInstant | 37278000000 | JPY |
| Treasury stock | Prior1YearInstant | -2978000000 | JPY |
| Treasury stock | CurrentYearInstant | -2963000000 | JPY |
| Shareholders equity | Prior1YearInstant | 50740000000 | JPY |
| Shareholders equity | CurrentYearInstant | 53761000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 555000000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | 741000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | － | JPY |
| Deferred gains or losses on hedges | CurrentYearInstant | -0 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 146000000 | JPY |
| Foreign currency translation adjustment | CurrentYearInstant | 731000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -20000000 | JPY |
| Remeasurements of defined benefit plans | CurrentYearInstant | 132000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 681000000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 1604000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 740000000 | JPY |
| Subscription rights to shares | CurrentYearInstant | 812000000 | JPY |
| Non controlling interests | Prior1YearInstant | 251000000 | JPY |
| Non controlling interests | CurrentYearInstant | 297000000 | JPY |
| Net assets | Prior1YearInstant | 52413000000 | JPY |
| Net assets | CurrentYearInstant | 56475000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 94937000000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 102226000000 | JPY |
| Net sales | Prior1YearDuration | 34343000000 | JPY |
| Net sales | CurrentYearDuration | 42871000000 | JPY |
| Cost of sales | Prior1YearDuration | 8886000000 | JPY |
| Cost of sales | CurrentYearDuration | 11620000000 | JPY |
| Gross profit | Prior1YearDuration | 25456000000 | JPY |
| Gross profit | CurrentYearDuration | 31251000000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 20480000000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration | 23719000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |